| 000 | 00876 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250514204857.0 | ||
| 264 | 0 | _c20050202 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a1444-0903 | ||
| 024 | 7 |
_a10.1111/j.1445-5994.2004.00692.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarks, D I | |
| 245 | 0 | 0 |
_aAntifungal guidelines. _h[electronic resource] |
| 260 |
_bInternal medicine journal _c |
||
| 300 |
_a586; author reply 586-7 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 773 | 0 |
_tInternal medicine journal _gvol. 34 _gno. 9-10 _gp. 586; author reply 586-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1445-5994.2004.00692.x _zAvailable from publisher's website |
| 999 |
_c15173061 _d15173061 |
||